Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

PLBY Group (NASDAQ:PLBY) reported first-quarter 2026 revenue growth and a narrower loss as management said its strategy to focus Playboy around licensing, media and experiences, hospitality and Honey Birdette is beginning to show results. On the company’s earnings call, Chief Executive Officer Ben

MarketBeat

Microvast Q1 Earnings Call Highlights

Microvast (NASDAQ:MVST) reported a sharp year-over-year revenue decline in the first quarter of 2026, while management said the drop reflected temporary timing and market challenges rather than a change in the company’s long-term growth strategy. The battery technology company posted first-quarter

MarketBeat

Marathon Digital Q1 Earnings Call Highlights

Marathon Digital (NASDAQ:MARA) executives said the company used the first quarter of fiscal 2026 to accelerate its shift from a pure-play Bitcoin miner toward a broader digital infrastructure business focused on power-backed AI, high-performance computing and critical IT workloads. Chairman and CEO

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Life360 Q1 Earnings Call Highlights

Life360 (NASDAQ:LIF) reported record first-quarter revenue and raised its full-year outlook, while management said technical issues temporarily weighed on user registration during the quarter but did not derail subscription momentum. Chief Executive Lauren Antonoff said the company’s revenue growth

MarketBeat

LENZ Therapeutics Q1 Earnings Call Highlights

LENZ Therapeutics (NASDAQ:LENZ) reported first-quarter 2026 results that showed continued prescription growth for its presbyopia eye drop VIZZ, while management acknowledged that new patient adoption and routine prescribing by eye care professionals are developing more gradually than expected. Pres

MarketBeat

aTyr Pharma Revamps Efzofitimod Path With New Phase III Sarcoidosis Trial

aTyr Pharma (NASDAQ:ATYR) said it plans to conduct a new Phase III trial of efzofitimod in pulmonary sarcoidosis after receiving feedback from the U.S. Food and Drug Administration at a recent Type C meeting. President and CEO Dr. Sanjay Shukla said the meeting, held in mid-April with official minu

MarketBeat

Kaltura Q1 Earnings Call Highlights

Kaltura (NASDAQ:KLTR) reported first-quarter 2026 results that exceeded its guidance for revenue and adjusted EBITDA, while also generating positive operating cash flow in a first quarter for the first time in the company’s history, executives said on the company’s earnings call. Co-founder, Chairm

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Harmonic Q1 Earnings Call Highlights

Harmonic (NASDAQ:HLIT) reported a stronger-than-expected first quarter for fiscal 2026, driven by sharp growth in its broadband business and broader adoption beyond its largest customers, according to comments from executives on the company’s earnings call. President and CEO Nimrod Ben-Natan said t

MarketBeat

iHeartMedia Q1 Earnings Call Highlights

iHeartMedia (NASDAQ:IHRT) reported first-quarter 2026 revenue growth that met management’s expectations, while adjusted earnings came in modestly below guidance as the company cited timing of non-cash marketing expenses and softer March advertising demand. Chairman and CEO Bob Pittman said consolid

MarketBeat

Health Catalyst Q1 Earnings Call Highlights

Health Catalyst (NASDAQ:HCAT) reported first-quarter 2026 results that topped its own expectations, while management outlined a broad restructuring plan aimed at simplifying the company’s operating model, reducing costs and shifting the business further toward technology-led growth. Chief Executive

MarketBeat

Hf Foods Group Q1 Earnings Call Highlights

Hf Foods Group (NASDAQ:HFFG) reported higher first-quarter revenue and improved profitability as management said volume growth, cost controls and operational changes helped offset pressure from product mix, tariffs and rising fuel costs. The Asian specialty food distributor posted net revenue of $3

MarketBeat

GoPro Q1 Earnings Call Highlights

GoPro (NASDAQ:GPRO) said it has begun a strategic review after receiving inbound merger-and-acquisition interest tied to its exploration of defense and aerospace opportunities, while reporting lower first-quarter revenue and a wider loss. Founder and CEO Nicholas Woodman said on the company’s first

MarketBeat

Halozyme Therapeutics Q1 Earnings Call Highlights

Halozyme Therapeutics (NASDAQ:HALO) reported a sharp increase in first-quarter 2026 revenue and earnings, driven by continued growth in royalties from its ENHANZE drug-delivery platform, and announced a new $1 billion share repurchase authorization. On the company’s earnings call, President and CEO

MarketBeat

Viant Technology Q1 Earnings Call Highlights

Viant Technology (NASDAQ:DSP) reported record first-quarter 2026 results and said it expects growth to accelerate through the year, citing strong connected TV demand, new customer ramps, artificial intelligence products and its recently closed acquisition of TVision. Chief Executive Officer Tim Van

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

DocGo Q1 Earnings Call Highlights

DocGo (NASDAQ:DCGO) reported first-quarter revenue of $75.6 million and an adjusted EBITDA loss of $10.2 million, as executives pointed to accelerating demand in virtual care, medical transportation and mobile health services while acknowledging pressure from fuel costs and labor-related investments

MarketBeat

CVRx Q1 Earnings Call Highlights

CVRx (NASDAQ:CVRX) reported first-quarter 2026 revenue of $14.8 million, up 20% from the prior-year period, as U.S. growth in its Barostim heart failure business helped the company exceed the high end of its guidance range, executives said on the company’s earnings call. President and Chief Executi

MarketBeat

Conduent Q1 Earnings Call Highlights

Conduent (NASDAQ:CNDT) reported improved profitability and cash flow in the first quarter of 2026 while outlining a broader plan to reduce costs, sharpen its commercial focus and use artificial intelligence to support margin expansion. Chief Executive Harsha Agadi, who said he has been in the role

MarketBeat

AST SpaceMobile Q1 Earnings Call Highlights

AST SpaceMobile (NASDAQ:ASTS) said it remains on track with its 2026 deployment and revenue plans as the satellite-to-smartphone company works to scale manufacturing, launch additional BlueBird satellites and move closer to commercial service activation in key markets. On the company’s first-quarte

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Coherus Oncology Q1 Earnings Call Highlights

Coherus Oncology (NASDAQ:CHRS) said it expects revenue growth for its nasopharyngeal cancer drug LOQTORZI to build through the rest of 2026, while the company prepares for multiple clinical data readouts across its oncology pipeline later this year. On the company’s first-quarter 2026 earnings call

MarketBeat

American Public Education Q1 Earnings Call Highlights

American Public Education (NASDAQ:APEI) reported higher first-quarter 2026 revenue and profitability, raised its full-year outlook and said its newly reorganized business structure is beginning to show operating leverage. President and Chief Executive Officer Angela Selden said total revenue rose 6

MarketBeat

AlTi Global Q1 Earnings Call Highlights

AlTi Global (NASDAQ:ALTI) reported higher first-quarter 2026 revenue and adjusted EBITDA, as management said recurring advisory fees and incentive income from investment distributions helped offset pressure from a volatile market environment. The wealth and asset management firm generated total rev

MarketBeat

Blink Charging Q1 Earnings Call Highlights

Blink Charging (NASDAQ:BLNK) executives said the company’s first-quarter 2026 results showed progress in its push toward recurring revenue, lower costs and a larger owned DC fast-charging network, while total revenue remained essentially flat from a year earlier. President and CEO Mike Battaglia sa

MarketBeat

Cleanspark Q2 Earnings Call Highlights

Cleanspark (NASDAQ:CLSK) reported fiscal second-quarter 2026 results while emphasizing its ongoing shift from a bitcoin mining-focused operator toward a broader digital infrastructure and data center development platform aimed at serving artificial intelligence and high-performance computing demand.

MarketBeat

CeriBell Q1 Earnings Call Highlights

CeriBell (NASDAQ:CBLL) reported first-quarter revenue growth of 29% and raised its full-year outlook, as management cited higher usage of its seizure monitoring system and the company’s strongest quarter of net new hospital additions since becoming public. On the company’s earnings call, Co-founder

MarketBeat

AbCellera Biologics Q1 Earnings Call Highlights

AbCellera Biologics (NASDAQ:ABCL) said its first quarter of 2026 was marked by progress in its internal drug pipeline, including interim Phase 1 data for its lead program, ABCL635, and continued preparation for multiple clinical catalysts expected over the next two years. President and CEO Dr. Carl

1 … 76 77 78 79

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.